OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0694-AI84 View EO 12866 Meetings | Received Date: 08/01/2022 |
Title: Request for Comments Concerning the Imposition of Emerging Technology Export Controls on Instruments for the Automated Chemical Synthesis of Peptides | |
Agency/Subagency: DOC / BIS | Stage: Prerule |
Concluded Action: Consistent with Change | Concluded Date: 08/26/2022 |
Section 3(f)(1) Significant *: No | |
Legal Deadline: None | Economically Significant **: No |
Publication Date: | Unfunded Mandates: No |
Major: No | Related To Homeland Security: Yes |
Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: Yes | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: No | |
|